Science Inventory

THE ROLE OF MEMBRANE TRANSPORTERS IN THE CELLULAR METABOLISM OF ARSENIC

Citation:

DROBNA, Z., A. HERNANDEZ-ZAVALA, V. DEVESA I PEREZ, D. J. THOMAS, AND M. STYBLO. THE ROLE OF MEMBRANE TRANSPORTERS IN THE CELLULAR METABOLISM OF ARSENIC. Presented at Society of Toxicology Annual Meeting, Charlotte, NC, March 25 - 29, 2007.

Description:

Arsenic (+3 oxidation state) methyltransferase (AS3MT) catalyzes methylation of inorganic arsenic (iAs) in humans. In this pathway iAs is converted to mono- (MAs) and dimethylated (DMAs) metabolites containing either AsIII or AsV. Because toxicities and metabolic fates of these metabolites differ, the overall toxicity associated with exposure to iAs depends on the pattern and extent of its conversion to metabolites. In a clonal human urothelial cell line expressing rat AS3MT (UROtsa/F35) iAsIII is more cytotoxic than in parental UROtsa cells that neither express AS3MT nor methylate iAs. Increased cytotoxicity of iAsIII in UROtsa/F35 cells has been associated with production and retention of MAs. Here, we examined the roles of membrane transporters, multidrug resistance associated proteins (MRPs), and P-glycoprotein (P-gp), in production and retention of iAs metabolites in UROtsa and UROtsa/F35 cells. Retention and methylation of arsenicals were examined in cells in which MRPs or P-gp were inhibited or in untreated cells after exposure to 1 µM iAsIII, MAsIII, or DMAsIII for 2 or 24 h.. After 2-h exposure, Inhibition of MRP or P-gp significantly increased MAsIII accumulation in either cell line and slightly increased DMAs production in MAsIII-treated UROtsa/F35 cells. MRP and P-gp inhibition also increased MAsIII accumulation in UROtsa cells after 24-h exposure. Neither cellular retention nor methylation rate was affected in UROtsa/F35 cells which converted MAsIII to DMAs. Retention and methylation rates were unaffected in UROtsa or UROtsa/F35 cells exposed to iAsIII or DMAsIII for 2 or 24 h. Hence, MRPs or P-gp may play a key role in efflux of MAsIII, a toxic intermediate in iAs metabolism, cells with limited capacity to convert MAsIII to DMAs. (This abstract does not reflect EPA policy.)

Record Details:

Record Type:DOCUMENT( PRESENTATION/ ABSTRACT)
Product Published Date:03/26/2007
Record Last Revised:04/09/2007
Record ID: 161145